Total Payments
$154,285
2022 Payments
$200.46
Companies
36
Transactions
634
Medicare Patients
1,087
Medicare Billing
$200,829
Payment Breakdown by Category
Other$129,501 (83.9%)
Travel$11,626 (7.5%)
Food & Beverage$9,658 (6.3%)
Consulting$3,350 (2.2%)
Education$149.52 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $129,501 | 55 | 83.9% |
| Travel and Lodging | $11,626 | 92 | 7.5% |
| Food and Beverage | $9,658 | 478 | 6.3% |
| Consulting Fee | $3,350 | 1 | 2.2% |
| Education | $149.52 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $65,381 | 209 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $63,712 | 188 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $10,691 | 27 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $4,768 | 38 | $0 (2020) |
| ViiV Healthcare Company | $3,638 | 4 | $0 (2019) |
| Mylan Specialty L.P. | $3,308 | 26 | $0 (2020) |
| Genentech USA, Inc. | $452.16 | 16 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $302.91 | 23 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $260.77 | 14 | $0 (2022) |
| PFIZER INC. | $259.27 | 14 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $200.46 | 4 | Inspire Medical Systems, Inc. ($123.26) |
| 2021 | $3,716 | 13 | GlaxoSmithKline, LLC. ($3,615) |
| 2020 | $40,133 | 61 | GlaxoSmithKline, LLC. ($39,615) |
| 2019 | $42,744 | 178 | GlaxoSmithKline, LLC. ($21,332) |
| 2018 | $42,857 | 214 | Sunovion Pharmaceuticals Inc. ($39,120) |
| 2017 | $24,635 | 164 | Sunovion Pharmaceuticals Inc. ($20,182) |
All Payment Transactions
634 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2022 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 09/20/2022 | Inspire Medical Systems, Inc. | Inspire Upper Airway Stimulation System (Device) | Food and Beverage | Cash or cash equivalent | $123.26 | General |
| Category: Neurology | ||||||
| 08/03/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $37.74 | General |
| Category: Cardiology | ||||||
| 02/07/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Cardiology | ||||||
| 09/21/2021 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 08/31/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Cardiology | ||||||
| 06/22/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Cardiology | ||||||
| 02/11/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 02/03/2021 | Teva Pharmaceuticals USA, Inc. | ArmonAir Digihaler (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Respiratory | ||||||
| 02/02/2021 | Melinta Therapeutics, LLC | Baxdela (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: ANTIBIOTICS | ||||||
| 01/29/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 01/20/2021 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.10 | General |
| Category: HFCWO | ||||||
| 01/20/2021 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.10 | General |
| Category: HFCWO | ||||||
| 01/19/2021 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.80 | General |
| Category: HFCWO | ||||||
| 01/19/2021 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.80 | General |
| Category: HFCWO | ||||||
| 01/19/2021 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.01 | General |
| Category: HFCWO | ||||||
| 01/19/2021 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.01 | General |
| Category: HFCWO | ||||||
| 12/16/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $85.09 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2020 | Jazz Pharmaceuticals Inc. | XYWAV (Drug), SUNOSI | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Respiratory | ||||||
| 11/19/2020 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardio-pulmonary | ||||||
| 11/11/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: RESPIRATORY | ||||||
| 11/10/2020 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/10/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Education | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 36 | 36 | $35,962 | $6,254 |
| 2022 | 3 | 64 | 88 | $73,698 | $13,838 |
| 2021 | 8 | 290 | 427 | $91,950 | $29,046 |
| 2020 | 13 | 697 | 1,956 | $306,383 | $151,692 |
Total Patients
1,087
Total Services
2,507
Medicare Billing
$200,829
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 36 | 36 | $35,962 | $6,254 | 17.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 37 | 61 | $55,083 | $10,604 | 19.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $9,760 | $2,495 | 25.6% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 11 | 11 | $8,855 | $739.96 | 8.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 25 | 44 | $36,567 | $7,660 | 20.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 116 | $14,500 | $6,763 | 46.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 35 | 74 | $15,615 | $6,093 | 39.0% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 48 | 48 | $7,200 | $2,157 | 30.0% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 43 | 43 | $6,450 | $1,804 | 28.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 38 | 38 | $2,578 | $1,719 | 66.7% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 48 | 48 | $7,200 | $1,674 | 23.3% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 16 | 16 | $1,840 | $1,176 | 63.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 162 | 940 | $117,500 | $54,882 | 46.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 153 | 519 | $96,015 | $43,678 | 45.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 28 | 93 | $25,110 | $16,992 | 67.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 74 | 78 | $19,500 | $12,855 | 65.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 90 | 130 | $16,900 | $10,256 | 60.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 33 | 33 | $7,425 | $3,721 | 50.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $6,815 | $3,027 | 44.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 42 | $4,116 | $2,168 | 52.7% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 22 | 22 | $3,300 | $986.23 | 29.9% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 21 | 21 | $3,150 | $913.90 | 29.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 18 | 18 | $2,970 | $877.77 | 29.6% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2020 | 18 | 18 | $2,700 | $746.64 | 27.7% |
| 87426 | Coronavirus ag ia | Office | 2020 | 13 | 13 | $881.92 | $587.99 | 66.7% |
About Dr. Remberto Bitar, M.D
Dr. Remberto Bitar, M.D is a Critical Care Medicine healthcare provider based in Kissimmee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386609899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Remberto Bitar, M.D has received a total of $154,285 in payments from pharmaceutical and medical device companies, with $200.46 received in 2022. These payments were reported across 634 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($129,501).
As a Medicare-enrolled provider, Bitar has provided services to 1,087 Medicare beneficiaries, totaling 2,507 services with total Medicare billing of $200,829. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Pulmonary Disease
- Location Kissimmee, FL
- Active Since 04/18/2006
- Last Updated 07/30/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386609899
Products in Payments
- TRELEGY ELLIPTA (Drug) $62,621
- LONHALA MAGNAIR (Drug) $30,345
- UTIBRON (Drug) $28,691
- Adempas (Drug) $10,691
- Yupelri (Drug) $3,179
- SEEBRI (Drug) $2,503
- Utibron (Drug) $2,097
- ANORO (Drug) $1,724
- NUCALA (Biological) $699.39
- SYMBICORT (Drug) $335.73
- Esbriet (Biological) $251.12
- BREO (Drug) $240.53
- FASENRA (Drug) $199.84
- ENTRESTO (Drug) $188.71
- ZERBAXA (Drug) $188.53
- ELIQUIS (Drug) $187.74
- Dymista (Drug) $128.36
- UPTRAVI (Drug) $127.39
- Inspire Upper Airway Stimulation System (Device) $123.26
- ACTHAR (Biological) $120.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Kissimmee
Dr. Thomas O'brien, Md, MD
Critical Care Medicine — Payments: $316,576
Critical Care Medicine $316,576
Maximo Lama, Md, MD
Critical Care Medicine — Payments: $240,452
Critical Care Medicine $240,452
Nelson Medina Villanueva
Critical Care Medicine — Payments: $14,472
Critical Care Medicine $14,472
Dr. Adam Griggs, D.o, D.O
Critical Care Medicine — Payments: $11,873
Critical Care Medicine $11,873
Mrs. Dawna Hazelwood, Aprn Agacnp-Bc, APRN AGACNP-BC
Critical Care Medicine — Payments: $1,448
Critical Care Medicine $1,448
Rami Hanna, Md, MD
Critical Care Medicine — Payments: $16.95
Critical Care Medicine $16.95